Pharsight

1. List of Dymista drug patents

Application	Filing Date	Opposition Party	Legal Status
EP09075100A	2016-04-11	Sanovel IIaç San. ve Tic. A.S.	Revoked
EP09075101A	2014-10-29	Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi	Revoked
EP09075101A	2014-10-24	Sanovel IIaç San. ve Tic. A.S.	Revoked
EP03738280A	2010-01-14	Glaxo Group Limited	Revoked

Patent	Proceeding Filing Date	Status	Respondent	Petitioner
US8163723	January, 2020	Terminated-Denied	Cipla Limited	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
US8168620	January, 2020	Terminated-Denied	Cipla Limited	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
US9259428	January, 2020	Terminated-Denied	Cipla Limited	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
US9901585	January, 2020	Terminated-Denied	Cipla Limited	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
US8168620	February, 2017	Terminated-Settled	Cipla Limited	Argentum Pharmaceuticals LLC

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9901585	MYLAN SPECIALITY LP	Combination of azelastine and fluticasone for nasal administration	Jun, 2023 (2 months from now)
US9259428	MYLAN SPECIALITY LP	Combination of azelastine and fluticasone for nasal administration	Jun, 2023 (2 months from now)
US8163723	MYLAN SPECIALITY LP	Combination of azelastine and steroids	Aug, 2023 (5 months from now)
US9259428 (Pediatric)	MYLAN SPECIALITY LP	Combination of azelastine and fluticasone for nasal administration	Dec, 2023 (8 months from now)
US8163723 (Pediatric)	MYLAN SPECIALITY LP	Combination of azelastine and steroids	Feb, 2024 (11 months from now)
US8168620	MYLAN SPECIALITY LP	Combination of azelastine and steroids	Feb, 2026 (2 years from now)
US8168620 (Pediatric)	MYLAN SPECIALITY LP	Combination of azelastine and steroids	Aug, 2026 (3 years from now)

Market Authorisation Date: 01 May, 2012

Treatment: Treatment of seasonal allergic rhinitis; Treatment of allergic rhinitis, including seasonal allergic rhinitis; Allergic rhinitis; Treatment of symptoms of seasonal allergic rhinitis; Relief of symptoms associated with seasonal allergic rhinitis

Dosage: SPRAY, METERED;NASAL